These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34416923)

  • 1. Hyaluronic acid synthesis, degradation, and crosslinking in equine osteoarthritis: TNF-α-TSG-6-mediated HC-HA formation.
    Fasanello DC; Su J; Deng S; Yin R; Colville MJ; Berenson JM; Kelly CM; Freer H; Rollins A; Wagner B; Rivas F; Hall AR; Rahbar E; DeAngelis PL; Paszek MJ; Reesink HL
    Arthritis Res Ther; 2021 Aug; 23(1):218. PubMed ID: 34416923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSG-6 - a double-edged sword for osteoarthritis (OA).
    Chou CH; Attarian DE; Wisniewski HG; Band PA; Kraus VB
    Osteoarthritis Cartilage; 2018 Feb; 26(2):245-254. PubMed ID: 29129649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synovial fluid lubricin and hyaluronan are altered in equine osteochondral fragmentation, cartilage impact injury, and full-thickness cartilage defect models.
    Peal BT; Gagliardi R; Su J; Fortier LA; Delco ML; Nixon AJ; Reesink HL
    J Orthop Res; 2020 Aug; 38(8):1826-1835. PubMed ID: 31965593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effect of experimentally induced cartilage defect and intra-articular hyaluronan on synovial fluid biomarkers in intercarpal joints of horses.
    Niemelä TM; Tulamo RM; Carmona JU; López C
    Acta Vet Scand; 2019 May; 61(1):24. PubMed ID: 31146775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent?
    Ghosh P; Guidolin D
    Semin Arthritis Rheum; 2002 Aug; 32(1):10-37. PubMed ID: 12219318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of synovial fluid lubricants and inflammatory cytokines in the horse: a comparison of recombinant equine interleukin 1 beta-induced synovitis and joint lavage models.
    Watkins A; Fasanello D; Stefanovski D; Schurer S; Caracappa K; D'Agostino A; Costello E; Freer H; Rollins A; Read C; Su J; Colville M; Paszek M; Wagner B; Reesink H
    BMC Vet Res; 2021 May; 17(1):189. PubMed ID: 33980227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cartilage oligomeric matrix protein and hyaluronan levels in synovial fluid from horses with osteoarthritis of the tarsometatarsal joint compared to a control population.
    Taylor SE; Weaver MP; Pitsillides AA; Wheeler BT; Wheeler-Jones CP; Shaw DJ; Smith RK
    Equine Vet J; 2006 Nov; 38(6):502-7. PubMed ID: 17124839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive expression of inter-α-inhibitor (IαI) family proteins and tumor necrosis factor-stimulated gene-6 (TSG-6) by human amniotic membrane epithelial and stromal cells supporting formation of the heavy chain-hyaluronan (HC-HA) complex.
    Zhang S; He H; Day AJ; Tseng SC
    J Biol Chem; 2012 Apr; 287(15):12433-44. PubMed ID: 22351758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteoglycan-4 and hyaluronan composition in synovial fluid and serum from clinical equine subjects: relationship to cartilage boundary lubrication and viscosity of synovial fluid.
    Matheson A; Regmi SC; Martin-Alarcon L; Jay GD; Scott WM; Schmidt TA
    Connect Tissue Res; 2021 Jul; 62(4):369-380. PubMed ID: 32306780
    [No Abstract]   [Full Text] [Related]  

  • 10. Superficial zone chondrocytes in normal and osteoarthritic human articular cartilages synthesize novel truncated forms of inter-alpha-trypsin inhibitor heavy chains which are attached to a chondroitin sulfate proteoglycan other than bikunin.
    Yoshihara Y; Plaas A; Osborn B; Margulis A; Nelson F; Stewart M; Rugg MS; Milner CM; Day AJ; Nemoto K; Sandy JD
    Osteoarthritis Cartilage; 2008 Nov; 16(11):1343-55. PubMed ID: 18524635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of inter-alpha-inhibitor heavy chain transfer on to hyaluronan.
    Milner CM; Tongsoongnoen W; Rugg MS; Day AJ
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):672-6. PubMed ID: 17635118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal changes in synovial fluid composition and elastoviscous lubrication in the equine carpal fracture model.
    Feeney E; Peal BT; Inglis JE; Su J; Nixon AJ; Bonassar LJ; Reesink HL
    J Orthop Res; 2019 May; 37(5):1071-1079. PubMed ID: 30859611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial fluid hyaluronan mediates MSC attachment to cartilage, a potential novel mechanism contributing to cartilage repair in osteoarthritis using knee joint distraction.
    Baboolal TG; Mastbergen SC; Jones E; Calder SJ; Lafeber FP; McGonagle D
    Ann Rheum Dis; 2016 May; 75(5):908-15. PubMed ID: 25948596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis.
    Sundman EA; Cole BJ; Karas V; Della Valle C; Tetreault MW; Mohammed HO; Fortier LA
    Am J Sports Med; 2014 Jan; 42(1):35-41. PubMed ID: 24192391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recombinant Link module of human TSG-6 suppresses cartilage damage in models of osteoarthritis: A potential disease-modifying OA drug.
    Drummond SP; Bartnik E; Kouvatsos N; Scott JL; Dyer DP; Thomson JM; Price AJ; Anand S; Biant LC; Leeuw T; Herrmann M; Milner CM; Day AJ
    Osteoarthritis Cartilage; 2023 Oct; 31(10):1353-1364. PubMed ID: 37257556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid complexes of high and low molecular weight: evaluation using an in vitro model of osteoarthritis.
    Stellavato A; De Novellis F; Reale S; De Rosa M; Schiraldi C
    J Biol Regul Homeost Agents; 2016; 30(4 Suppl 1):7-16. PubMed ID: 28002895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility.
    Reesink HL; Sutton RM; Shurer CR; Peterson RP; Tan JS; Su J; Paszek MJ; Nixon AJ
    Stem Cell Res Ther; 2017 Nov; 8(1):243. PubMed ID: 29096716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravascular heavy chain-modification of hyaluronan during endotoxic shock.
    Ni K; Gill A; Cao D; Koike K; Schweitzer KS; Garantziotis S; Petrache I
    Biochem Biophys Rep; 2019 Mar; 17():114-121. PubMed ID: 30623115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Analysis of the Size Distribution of Heavy Chain-Modified Hyaluronan with Solid-State Nanopores.
    Erxleben DA; Dodd RJ; Day AJ; Green DE; DeAngelis PL; Poddar S; Enghild JJ; Huebner JL; Kraus VB; Watkins AR; Reesink HL; Rahbar E; Hall AR
    Anal Chem; 2024 Jan; 96(4):1606-1613. PubMed ID: 38215004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis.
    Wang CT; Lin YT; Chiang BL; Lin YH; Hou SM
    Osteoarthritis Cartilage; 2006 Dec; 14(12):1237-47. PubMed ID: 16806998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.